Type 2 deiodinase

Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment

M. Luo, Zhou, X. H., Zou, T., Keyim, K., and Dong, L. M., Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment, vol. 14, pp. 5407-5416, 2015.

We investigated type II deiodinase (DIO2) polymorphisms and serum thyroid hormone levels in subjects with mild cognitive impairment (MCI) in a Uygur population. We studied the DIO2 Thr92Ala (rs225014) and ORFa-Gly3Asp (rs12885300) polymorphisms of 129 unrelated MCI cases and 131 matched controls. All subjects were genotyped using SNaPshot SNP genotyping assays. Serum thyroid hormone levels were measured by radioimmunoassay. Levels of serum triiodothyronine and thyroxine in the MCI group were significantly lower than those in the control group.

Subscribe to Type 2 deiodinase